MEREDITH LUCAS: Open Payments
NPI 1083310122 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$848 in 11 payments from 7 companies in 2025. Trend: 2023 $65 · 2024 $150 · 2025 $848
Food & beverage: $848
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $136 |
| Janssen Pharmaceuticals, Inc | 1 | $133 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| Otsuka America Pharmaceutical, Inc. | 1 | $120 |
| Axsome Therapeutics, Inc. | 1 | $115 |
| Novo Nordisk Inc | 1 | $112 |
| BioCryst US Sales Co., LLC | 5 | $109 |
Products named: COBENFY, INVEGA SUSTENNA, AUSTEDO XR, REXULTI, Auvelity, Ozempic, ORLADEYO.
Industry payments across MO — which companies pay providers there.
